Open original FDA record ↗Recall record
- FDA identifier
- Z-0188-2013
- Company in FDA record
- Roche Molecular Systems, Inc.
- FDA classification date
- Nov 2, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class III
Reason stated in the source
It was identified that BRAF controls dispositioned as "Internal Use Only" were incorrectly packaged into cobas 4800 BRAF V600 Mutation Test CE-IVD kit lot R03607 and released for distribution. Two control batches manufactured during two process validation studies are involved: PV7711: BRAF Mutant (MUT) Control PV0853: BRAF Wild Type (WT) Control
Source facts
- Action
- Roche sent a Safety Board Notice - Product Bulletin 2012-013 on 31-Jul-2012 to affected customers. The notice identifed the affected product, description of situation and actios to be taken. Customers were instructed to discontinue use, quarantine and discard any remaining kits of the affected product in inventory. Customers were advised to contact their affiliate sales office for replacement. The notice states a new cobas 4800 BRAF V600 Mutation Test lot (R07749) is anticipated to be available on 03-Aug-2012. For questions call +01.908.253.7569.
- Initiated
- 2012-07-31
- Root cause
- Mixed-up of materials/components
- Terminated
- 2013-09-11
- Distribution
- Worldwide Distribution - Australia, Austria, Belgium, China, Hungary, Turkey and United Kingdom.
- Recall number
- Z-0188-2013
- Recall status
- Terminated
- CDRH record ID
- 113477
- FDA classified
- 2012-11-02
- Recall event number
- 63310